Sionna Therapeutics (NASDAQ:SION) Stock Price Down 4% - Here's Why - MarketBeat
7 hours ago • Google News
Sionna Therapeutics, Inc. Common Stock (SION)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 768.97M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 26.50
52W Low
$ 7.25
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
15.8833
200-Day MA
14.9346
52 Week High
26.5
52 Week Low
7.255
About SION
Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF).
Employees
41
Headquarters
Waltham, MA
CEO
Mr. Michael Cloonan M.B.A.